Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from Her-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Sep 8 2023
EventNeuro-Oncology -
Duration: Sep 8 2023 → …

Conference

ConferenceNeuro-Oncology
Period9/8/23 → …

Cite this